Government Affairs for
Emerging Biotech

Because Your Success is Someone’s Fighting Chance

Every Win is a Win for
Those You Serve

Your partner in the fight for biotech innovation

Emerging biotechs like yours are driving the future of medicine. In fact, ~70% of the nearly 3,000 therapies in Phase III clinical trials are from small pharmaceutical companies, and biotechs originate the majority of new FDA-approved drugs and medical advances.

Group of people, including individuals in wheelchairs, standing in front of the United States Capitol building in Washington, D.C.

With every breakthrough,
a life impacted

At KPM Group, we work with emerging biotech companies and specialize in rare disease. We’re here for those you’re working with to help with cures, therapies, treatment, and hope.  

Black and white photo of a laboratory microscope with a gloved hand adjusting the objective lens.

Our Services

Challenging the status quo, our strategies are bespoke, not borrowed.

We meet you where you are.

  • View of a grand domed ceiling with an ornate chandelier hanging from the center.

    Government Affairs & Advocacy

    By your side for whatever it takes. We’re your fractional government affairs support. Our customized approach meets your needs in active lobbying, strategic planning, and advocacy.

    Amplifying the voices of the patients you serve.

    LEARN MORE
  • Black and white photo of a chessboard with chess pieces, focusing on a white queen in the center.

    Consulting & Strategy

    We understand your unique challenges deeply. We keep you informed and up-to-date as your strategic partner, providing you with expert guidance and tailored recommendations. Powering your innovation with purpose. 

    Because they’ve been waiting long enough.

    LEARN MORE
  • A man in a suit giving a presentation at a conference, standing behind a podium with a sign that reads "The Business of Rare Policy Summit."

    Thought Leadership & Reputation

    With solutions that are anything but cookie-cutter, giving hope a seat at the table. Our thought leadership and reputation building set you apart from the status quo. 

    Where purpose meets policy, innovation meets impact. 

    LEARN MORE

We are your advocate, ally, and amplifier

Partnering with Biotech innovators who refuse to accept a world without hope

10-15 yrs. 

The average time it takes to
bring a drug to market 

12% 

The approximate number of drugs entering clinical trials that are ultimately approved by the FDA

While you’re fighting hard for your innovation, you’re in a race against time. You can’t afford to add months and years to the timeline with capital on the line. You hit walls and obstacles, face refusals and setbacks with the FDA, CMS, and in states. Visibility and funding are of the essence.

Having expert support is vital.
That’s where KPM comes in.

START A CONVERSATION

By your side, weathering every storm 

We give your patients a voice and a seat at the table

  • Close-up of a broken incandescent light bulb with sparks flying around it in a dark background.

    We See You

    25+ years of industry experience, we understand the challenges of emerging biotech deeply

  • A close-up of a person's hand moving a chess piece on a chessboard, black and white image.

    Fresh Thinking

    You won’t find outdated playbooks here; everything we do is tailored to your needs

  • Black and white photo of a compass showing north at the top, east to the right, south at the bottom, and west to the left, with the needle pointing towards northeast.

    Challenging the Status Quo

    We bring passion, diversity, and values

  • Black and white photo of the Washington Monument reflected in the water of the Tidal Basin, with cherry blossom trees along the shoreline and people walking, on a partly cloudy day.

    Restoring Warmth to Washington

    Everything we do connects back to the lives you’re changing

We do advocacy different,
because different is what works. 

LET'S GET TO WORK